KR100672269B1 - 심바스타틴의 제조 방법 - Google Patents

심바스타틴의 제조 방법 Download PDF

Info

Publication number
KR100672269B1
KR100672269B1 KR1020007008648A KR20007008648A KR100672269B1 KR 100672269 B1 KR100672269 B1 KR 100672269B1 KR 1020007008648 A KR1020007008648 A KR 1020007008648A KR 20007008648 A KR20007008648 A KR 20007008648A KR 100672269 B1 KR100672269 B1 KR 100672269B1
Authority
KR
South Korea
Prior art keywords
formula
group
acid
simvastatin
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020007008648A
Other languages
English (en)
Korean (ko)
Other versions
KR20010040760A (ko
Inventor
다오까나오아끼
이노우에겐지
Original Assignee
카네카 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 카네카 코포레이션 filed Critical 카네카 코포레이션
Publication of KR20010040760A publication Critical patent/KR20010040760A/ko
Application granted granted Critical
Publication of KR100672269B1 publication Critical patent/KR100672269B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
KR1020007008648A 1998-12-10 1999-12-10 심바스타틴의 제조 방법 Expired - Fee Related KR100672269B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35186598 1998-12-10
JP98-351865 1998-12-10

Publications (2)

Publication Number Publication Date
KR20010040760A KR20010040760A (ko) 2001-05-15
KR100672269B1 true KR100672269B1 (ko) 2007-01-23

Family

ID=18420148

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007008648A Expired - Fee Related KR100672269B1 (ko) 1998-12-10 1999-12-10 심바스타틴의 제조 방법

Country Status (14)

Country Link
US (1) US6331641B1 (enExample)
EP (2) EP1055671B1 (enExample)
JP (2) JP4440476B2 (enExample)
KR (1) KR100672269B1 (enExample)
CN (2) CN1122029C (enExample)
AT (1) ATE283849T1 (enExample)
AU (1) AU1683000A (enExample)
CA (1) CA2320163C (enExample)
CZ (2) CZ299522B6 (enExample)
DE (1) DE69922348T2 (enExample)
ES (1) ES2234323T3 (enExample)
HU (1) HUP0103021A3 (enExample)
SI (1) SI20327B (enExample)
WO (1) WO2000034264A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2127500A (en) 1999-11-11 2001-06-06 Biocon India Limited Process for manufacturing simvastatin and the novel intermediates
US6573385B1 (en) 1999-11-11 2003-06-03 Biocon India Limited Process for manufacturing simvastatin and novel intermediates thereof
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
KR100361833B1 (ko) * 2000-06-20 2002-11-22 주식회사 엘지생명과학 심바스타틴의 제조방법
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
IL159741A0 (en) * 2001-07-13 2004-06-20 Astrazeneca Uk Ltd Preparation of aminopyrimidine compounds
KR100435142B1 (ko) * 2002-01-09 2004-06-09 한미약품 주식회사 개선된 심바스타틴의 제조방법
KR100502834B1 (ko) * 2002-03-25 2005-07-20 보령제약 주식회사 개선된 락톤화 반응에 의한 심바스타틴의 제조방법 및이의 정제방법
KR100502833B1 (ko) * 2002-03-25 2005-07-25 보령제약 주식회사 심바스타틴 및 이의 중간체 화합물들의 개선된 제조방법
US6603022B1 (en) 2002-05-10 2003-08-05 Biocon India Limited Process for manufacturing Simvastatin and novel intermediates thereof
EP1375493A1 (en) * 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) * 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) * 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
US7700329B2 (en) * 2003-10-21 2010-04-20 Brian Morgan Methods for making simvastatin and intermediates
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
AU2003289546A1 (en) * 2003-12-16 2005-07-05 Uk Chemipharm Co., Ltd. Process for preparing simvastatin.
CN1754870A (zh) * 2004-09-30 2006-04-05 淮北市辉克药业有限公司 辛伐他汀的制备方法
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
US20110059493A1 (en) * 2007-08-27 2011-03-10 Brian Morgan Methods for Making Simvastatin and Intermediates
JP2009114121A (ja) * 2007-11-06 2009-05-28 Kaneka Corp シンバスタチンの製造方法
CN101575328B (zh) * 2008-05-09 2012-07-04 上海医药工业研究院 一种辛伐他汀中间体的合成方法
CN102690254B (zh) * 2008-05-09 2014-06-04 上海医药工业研究院 辛伐他汀铵盐中间体及其制备方法
CN110563680A (zh) * 2019-09-10 2019-12-13 山东罗欣药业集团恒欣药业有限公司 一种治疗高脂血症药物的制备方法
CN110483459A (zh) * 2019-09-10 2019-11-22 山东罗欣药业集团恒欣药业有限公司 一种辛伐他汀的合成方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81703B (en) * 1980-02-04 1982-09-29 Merck & Co Inc New antihypercholesterolemic compounds,intermediates and processes
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
JPS58188872A (ja) * 1982-04-26 1983-11-04 Suntory Ltd オクタヒドロナフタレン誘導体及びその製造法
US4837205A (en) * 1986-09-02 1989-06-06 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
US4916239A (en) * 1988-07-19 1990-04-10 Merck & Co., Inc. Process for the lactonization of mevinic acids and analogs thereof
GB8915280D0 (en) * 1989-07-04 1989-08-23 British Bio Technology Compounds
US5072002A (en) * 1989-07-18 1991-12-10 The Governors Of The University Of Alberta Synthesis of cholesterol-lowering agents
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives
EP0415488B1 (en) * 1989-08-31 1994-04-20 Merck & Co. Inc. 7-Substituted HMG-COA reductase inhibitors
US5393893A (en) * 1993-11-08 1995-02-28 Apotex, Inc. Process for producing simvastatin and analogs thereof
ES2131037T3 (es) * 1995-12-06 2001-12-16 Balkanpharma Razgrad Ad Procedimiento de preparacion de lovastatina.
US5763653A (en) * 1997-03-13 1998-06-09 Ranbaxy Laboratories, Ltd. Key intermediates in the manufacture of simvastatin
CA2185961A1 (en) * 1996-09-19 1998-03-20 K.S. Keshava Murthy Process for producing simvastatin
SI9700202A (sl) * 1997-01-24 1998-08-31 Ranbaxy Laboratories Limited Postopek izdelave simvastatina iz lovastatina ali mevinolinske kisline
US5763646A (en) * 1997-03-13 1998-06-09 Ranbaxy Laboratories, Ltd. Process for manufacturing simvastatin from lovastatin or mevinolinic acid
ES2197465T3 (es) * 1997-01-28 2004-01-01 Plus Chemicals B.V. Proceso para la produccion de estatinas semisinteticas a traves de nuevos intermedios.
SI9800057A (sl) * 1998-02-26 1999-08-31 Krka, Tovarna Zdravil, D.D. Postopek za pripravo simvastatina in njegovih derivatov
EP0940395A1 (en) * 1998-03-05 1999-09-08 Synthon B.V. Process for producing simvastatin and/or its derivatives

Also Published As

Publication number Publication date
DE69922348T2 (de) 2005-12-01
CA2320163A1 (en) 2000-06-15
US6331641B1 (en) 2001-12-18
EP1533308A2 (en) 2005-05-25
ATE283849T1 (de) 2004-12-15
EP1533308A3 (en) 2005-09-14
JP4440476B2 (ja) 2010-03-24
CA2320163C (en) 2008-09-23
CZ20003149A3 (cs) 2000-12-13
ES2234323T3 (es) 2005-06-16
KR20010040760A (ko) 2001-05-15
SI20327B (sl) 2015-02-27
CN1122029C (zh) 2003-09-24
HUP0103021A3 (en) 2002-04-29
JP5048709B2 (ja) 2012-10-17
HUP0103021A2 (hu) 2001-12-28
EP1055671A4 (en) 2002-05-08
CZ299522B6 (cs) 2008-08-27
AU1683000A (en) 2000-06-26
EP1533308B1 (en) 2014-01-15
DE69922348D1 (de) 2005-01-05
CN1226296C (zh) 2005-11-09
CN1493570A (zh) 2004-05-05
EP1055671B1 (en) 2004-12-01
SI20327A (sl) 2001-02-28
CN1290261A (zh) 2001-04-04
CZ299566B6 (cs) 2008-09-03
WO2000034264A1 (en) 2000-06-15
JP2009185041A (ja) 2009-08-20
EP1055671A1 (en) 2000-11-29

Similar Documents

Publication Publication Date Title
KR100672269B1 (ko) 심바스타틴의 제조 방법
JPWO2000034264A1 (ja) シンバスタチンの製造方法
US4820850A (en) Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US8258299B2 (en) Process for preparation of temsirolimus
EP1056737B1 (en) Process for the preparation of simvastatin and derivatives thereof
EP1363516B1 (en) An improved process for preparing simvastatin
KR20030069790A (ko) 이량체 불순물의 농도가 저하된 로바스타틴 및심바스타틴의 정제 방법
US7566792B2 (en) Method for the manufacture of Lovastatin
MXPA00007791A (en) Process for producing simvastatin
KR100322630B1 (ko) 심바스타틴및 이의 중간체 화합물을 제조하는 방법
KR100565958B1 (ko) 심바스타틴의 제조방법
WO2005069741A2 (en) Process for producing simvastatin using novel hydrazide intermediates
WO2007096753A2 (en) Process for preparing highly pure simvastatin
WO2002024675A1 (en) Process for manufacturing simvastatin and the novel intermediates
JP2005523303A (ja) 4−オキシテトラヒドロピラン−2−オンの製造方法
KR20030040858A (ko) 심바스타틴의 신규 제조방법
KR20040092790A (ko) 심바스타틴 중간체 제조방법
WO2005077928A1 (en) Improved process for producing simvastatin

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20121227

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20131218

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20150117

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20150117

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000